HomeIMUX • NASDAQ
add
Immunic Inc
Previous close
$0.70
Day range
$0.68 - $0.75
Year range
$0.56 - $2.11
Market cap
68.20M USD
Avg Volume
2.27M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 26.82M | 12.33% |
Net income | -25.47M | 13.90% |
Net profit margin | — | — |
Earnings per share | -0.25 | 16.67% |
EBITDA | -26.78M | -12.27% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.30M | -85.30% |
Total assets | 20.52M | -80.30% |
Total liabilities | 25.80M | 25.38% |
Total equity | -5.29M | — |
Shares outstanding | 95.82M | — |
Price to book | -11.69 | — |
Return on assets | -218.50% | — |
Return on capital | -887.01% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -25.47M | 13.90% |
Cash from operations | -21.78M | 9.15% |
Cash from investing | -47.00K | -51.61% |
Cash from financing | — | — |
Net change in cash | -21.36M | -142.19% |
Free cash flow | -12.34M | 23.85% |
About
CEO
Founded
May 2003
Website
Employees
90
